2020 American Transplant Congress
Proportion of Veillonella and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation
*Purpose: New-onset diabetes transplantation after transplantation (NODAT) is an important metabolic complication after kidney transplantation, although its mechanism is not yet fully elucidated. Recent studies…2020 American Transplant Congress
Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection – Molecular Rebound Phenomena Under IL-6 Blockade?
*Purpose: Late antibody-mediated rejection (ABMR) is well established as a major cause of kidney allograft failure. Targeting interleukin-6 (IL-6), a pro-inflammatory cytokine involved in B…2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Living Kidney Donors with Microscopic Hematuria
*Purpose: Potential kidney donors with isolated hematuria are often excluded from donating although there is a wide controversy about the definition and threshold of investigations…2020 American Transplant Congress
Non-Self-Advocacy is Associated with Improved Access to Living Donor Kidney Transplantation
University of Alabama at Birmingham Hospital, Birmingham, AL
*Purpose: Our Living Donor Navigator (LDN) program aims to help potential transplant recipients (PTRs) identify live donors with the help of an advocate. These advocates…2020 American Transplant Congress
Geographic Discard Disparities of Liver Allografts
1Medical Student, Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX
*Purpose: The aim of this study is to demonstrate the significant geographic disparity in liver allograft discard.*Methods: Using the OPTN Diseased Donor Network database, we…2020 American Transplant Congress
Incidence of Rejection One Year after Liver Transplantation Associated with Early versus Late Steroid Withdrawal
The Mount Sinai Hospital, New York, NY
*Purpose: The adverse effects associated with steroid use make earlier steroid withdrawal desirable, but the optimal time for withdrawal after liver transplantation (LT) is not…2020 American Transplant Congress
The Oncological Optimal Tacrolimus Target Level after Liver Transplant for Hepatocellular Carcinoma
1The Cleveland Clinic, Cleveland, OH, 2Duke University, Durham, NC, 3Chiba University, Chiba, Japan
*Purpose: The recurrence rate after liver transplant (LT) for hepatocellular carcinoma (HCC) is high as 15-20% nevertheless of complete removal of tumor and carcinogenic liver.…2020 American Transplant Congress
Cumulative United States Experience with Domino Liver Transplants
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: The ongoing shortage of livers in the setting of growing waiting lists remains a challenge in transplantation. First introduced in 1996, domino liver transplantation…2020 American Transplant Congress
Risk of Infectious Complications after GastroIntestinal Surgery in Renal Transplant Recipients
Temple University School of Medicine, Philadelphia, PA
*Purpose: Solid organ transplantation remains the preferred treatment for patients with end stage organ diseases. In 2018 alone, 36, 527 organ transplants were performed in…2020 American Transplant Congress
Incidence of Skin Cancer – A Long Term Outcome of Immunosuppression in Renal Transplant Recipients Associated with the Usage of Azathioprine
*Purpose: The main cause of mortality in Kidney Transplant Recipient’s (KTRs) is malignancy. The cancer incidence is increased by treating with immunosuppressive agents and longer…
- 1
- 2
- 3
- …
- 223
- Next Page »